Therapeutic Goods Advertising Code: Amendments
EXPLANATORY STATEMENT
Issued by the Authority of the Delegate of the Minister for Health and Ageing
Therapeutic Goods Act 1989
Therapeutic Goods Advertising Code: Amendments
The object of the Therapeutic Goods Act 1989 (the Act) is to establish and maintain a system of controls for the quality, safety, efficacy and timely availability of therapeutic goods that are used in Australia or exported from Australia. The Therapeutic Goods Administration (the TGA) is responsible for administering the Act.
The Act includes provisions relating to advertisements for therapeutic goods. Subsection 3(1) of the Act defines the Therapeutic Goods Advertising Code (TGAC) as the Code known by that name and “notified in the Gazette with effect from the date of commencement of Schedule 1 to the Therapeutic Goods Amendment Act (No.1) 2003 together with any amendments of the Code published by the Minister in the Gazette from time to time”.
The TGAC is now subject to the Legislative Instruments Act 2003 which was implemented on 1 January 2005, negating the need for the Minister to publish amendments in the Gazette, but requiring the TGAC and all subsequent amendments to be included in the Federal Register of Legislative Instruments.
The Minister’s delegate in the TGA approved a number of amendments to the TGAC on 20 January 2005 which became necessary to ensure consistency between the Code and the requirements specified in Schedule 1 to the Therapeutic Goods Amendment Act (No.1) 2003.
The amendments commence on 20 January 2005.
DETAILS OF AMENDMENTS TO THE THERAPEUTIC GOODS ADVERTISING CODE.
Clause 2.3 is amended to ensure the TGAC definition of “specified media” is the same as that contained in the Act.
Clause 2.5 is a new clause which adds to the TGAC, the new definition of “broadcast media”, as contained in the Act. The subsequent clauses have been appropriately re-numbered.
Clause 2.6 and Appendix 2 are amended to reflect the legislative amendment which moved the definition of “healthcare professional” from the Therapeutic Goods Regulations to the Act.
Appendix 3 is amended to update the contact details for the Advertising Services Managers who are appointed to pre-approve advertisements under the Regulations (prior to broadcast or publication) as Delegates of the Secretary to the Department of Health and Ageing.
Appendix 4 is amended to delete reference to the Broadcasting Services Act 1992, the legislation which previously established the advertising pre-approval scheme for broadcast media advertisements.
Overview
The Therapeutic Goods Act 1989 was enacted by the Parliament of Australia to regulate the quality, safety, efficacy, and timely availability of therapeutic goods within Australia and in export markets. This Act serves to establish a comprehensive framework overseen by the Therapeutic Goods Administration (TGA). A significant aspect of the Act involves the regulation of advertisements for therapeutic goods, ensuring that such advertisements comply with established standards to protect public health. The Therapeutic Goods Advertising Code (TGAC), as defined in the Act, is a pivotal component of this regulatory framework, and amendments to this Code are made to maintain alignment with legislative changes and ensure ongoing compliance. The Therapeutic Goods Advertising Code: Amendments made in 2005 aimed to bring the Code in line with recent legislative amendments, particularly those specified in the Therapeutic Goods Amendment Act (No.1) 2003, and to incorporate changes necessitated by the Legislative Instruments Act 2003, which impacts how legislative instruments, including the TGAC, are to be managed and published. These amendments underscore the policy objective of maintaining a coherent and effective regulatory environment for therapeutic goods advertising in Australia.
Scope and Application
The Therapeutic Goods Advertising Code: Amendments applies to all entities and individuals who are involved in the advertising of therapeutic goods in Australia, including pharmaceutical companies, healthcare providers, and advertising agencies. The amendments ensure that the Therapeutic Goods Advertising Code is consistent with the Therapeutic Goods Act 1989 and any relevant regulations. The amendments apply nationally and are administered by the Therapeutic Goods Administration (TGA), which is responsible for enforcing the Act. There are no stated exclusions or exemptions in the amendments themselves, but the Act may contain exclusions for certain types of therapeutic goods or advertising practices. The amendments extend the application of the TGAC by clarifying definitions and updating contact information, and they may be further extended or restricted by subordinate instruments such as regulations or guidelines issued by the TGA.
Key Provisions
The Therapeutic Goods Advertising Code: Amendments primarily focus on ensuring the Therapeutic Goods Advertising Code (TGAC) aligns with legislative requirements and reflects updates in definitions and contact details. Clause 2.3 has been amended to match the definition of “specified media” as it appears in the Therapeutic Goods Act 1989 (s.3(1)). This ensures that the TGAC reflects the same terminology used in the Act, thereby providing clarity and consistency in the interpretation and application of advertising regulations for therapeutic goods. Clause 2.5 introduces a new definition of “broadcast media” (s.3(1)) into the TGAC, which was previously defined in the Act but not in the TGAC. This amendment ensures that both the Act and the Code have consistent terminology regarding broadcast media, facilitating a uniform understanding of what constitutes broadcast media for the purposes of advertising therapeutic goods.
The obligations imposed by these amendments require that any advertisements for therapeutic goods must now comply with the updated definitions and procedural requirements stipulated in the TGAC. For instance, the amended definition of “healthcare professional” now being part of the Act (s.3(1)) means that all advertisements must accurately define and target this term as per the legislative framework. Furthermore, the inclusion of the new definition of “broadcast media” in the TGAC (s.2.5) necessitates that any advertisements intended for broadcast must be pre-approved by the Advertising Services Managers, as outlined in the Regulations (s.2.6). This ensures that all broadcast advertisements undergo a review process to ensure compliance with advertising standards before they are aired.
Breaches of the Therapeutic Goods Advertising Code can lead to significant consequences. Under the Therapeutic Goods Act 1989, any person who contravenes the provisions of the TGAC may be subject to enforcement actions. These actions can include fines, the requirement to cease the advertisement, and potentially more severe penalties depending on the nature and extent of the breach. The maximum penalties for contravening advertising provisions can include substantial financial penalties and, in cases of serious or repeated breaches, potential criminal charges. Such consequences underscore the importance of adhering to the updated TGAC and the necessity for entities to stay informed about legislative changes and their implications for advertising therapeutic goods.